Improving the Diagnostic of Tuberculosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

991 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-22

Study Completion Date

2019-02-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The presence of M. tuberculosis in non-invasive throat swabs of patients withdrawn for suspected tuberculosis.

Hypothesis 10% of patients infected by M. tuberculosis are carrier of M. tuberculosis pharyngeal.

Secondary

1. Measure the time to diagnosis of pulmonary TB by comparing the sample versus noninvasive pharyngeal samples taken routinely.
2. Evaluation of the direct cost of the diagnosis of M. tuberculosis by comparing the sample versus noninvasive pharyngeal samples taken routinely.
3. Beijing genotype prevalence among patients with pulmonary tuberculosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Serological Test for the Diagnosis of TB

NCT02898623

Active Tuberculosis

TERMINATED

Integrated Discovery and Development of Innovative TB Diagnostics

NCT06624501

Tuberculosis, Pulmonary

COMPLETED

Point-of-care Triage Test for Active Tuberculosis

NCT04232618

Tuberculosis Tuberculosis, Pulmonary

UNKNOWN

Comparison Between Two Strategies for the Diagnosis of TB

NCT02961569

Pulmonary TB

COMPLETED NA

Time-to-Detection in Culture of Mycobacterium Tuberculosis

NCT05568368

Pulmonary Tuberculoses

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

diagnosis of M.tuberculosis infection

Group Type EXPERIMENTAL

Pharyngeal swab

Intervention Type BIOLOGICAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharyngeal swab

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient taken for microbiological examinations "kit mycobacterium"
* Patient Major (\> 18 years).
* Patient who freely signed the informed written consent.

Exclusion Criteria

* Patient minor (\<18 years).
* Patient pregnant or nursing.
* Major Patient under guardianship.
* Private Patient liberty or under court order.
* Patient refusing to sign the informed consent form.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No